This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jul 6;103(13):994-5.

doi: 10.1093/jnci/djr223. Epub 2011 Jun 16.

Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel

Douglas A Corley

PMID: 21680911
DOI: 10.1093/jnci/djr223

Editorial

Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel

Douglas A Corley. J Natl Cancer Inst. 2011.

. 2011 Jul 6;103(13):994-5.

doi: 10.1093/jnci/djr223. Epub 2011 Jun 16.

Author

Douglas A Corley

PMID: 21680911
DOI: 10.1093/jnci/djr223

No abstract available

PubMed Disclaimer

Comment on

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ. Bhat S, et al. J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57. doi: 10.1093/jnci/djr203. Epub 2011 Jun 16. J Natl Cancer Inst. 2011. PMID: 21680910 Free PMC article.

Similar articles

Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL. Dulai GS, et al. Am J Gastroenterol. 2005 Apr;100(4):775-83. doi: 10.1111/j.1572-0241.2005.41300.x. Am J Gastroenterol. 2005. PMID: 15784018
Diagnosis and recognition of early esophageal neoplasia.
Herszényi L, Pregun I, Tulassay Z. Herszényi L, et al. Dig Dis. 2009;27(1):24-30. doi: 10.1159/000210100. Epub 2009 May 8. Dig Dis. 2009. PMID: 19439957 Review.
Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ. Bhat S, et al. J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57. doi: 10.1093/jnci/djr203. Epub 2011 Jun 16. J Natl Cancer Inst. 2011. PMID: 21680910 Free PMC article.
Barrett's esophagus and cancer risk: a more realistic estimate.
Rajendra S, Sharma P. Rajendra S, et al. Semin Thorac Cardiovasc Surg. 2011 Winter;23(4):261-2. doi: 10.1053/j.semtcvs.2012.01.003. Semin Thorac Cardiovasc Surg. 2011. PMID: 22443641
Risk factors for esophageal cancer development.
Falk GW. Falk GW. Surg Oncol Clin N Am. 2009 Jul;18(3):469-85. doi: 10.1016/j.soc.2009.03.005. Surg Oncol Clin N Am. 2009. PMID: 19500737 Review.

See all similar articles

Cited by

Cellular communication network 1 promotes CASP2 mRNA expression but suppresses its protein translation in esophageal adenocarcinoma.
Xu R, Jiang Z, Meng X, Xing L, Aladan W, Chi B, Dang T, Chai J. Xu R, et al. J Cell Commun Signal. 2024 Jul 17;18(3):e12046. doi: 10.1002/ccs3.12046. eCollection 2024 Sep. J Cell Commun Signal. 2024. PMID: 39524140 Free PMC article.
Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.
Pereira AD, Chaves P. Pereira AD, et al. United European Gastroenterol J. 2016 Jun;4(3):343-52. doi: 10.1177/2050640615612409. Epub 2015 Oct 30. United European Gastroenterol J. 2016. PMID: 27403300 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information